Fa-Po Chung

Dr. Fa-Po Chung

orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 June 2022 in Circulation
Verified
Journal Article
Closed access
PDF file
RTRoderick Tung
Roderick Tung
YXYumei Xue
Yumei Xue
MCminglong Chen
minglong Chen
CJChenyang Jiang
Chenyang Jiang
DSDalise Y. Shatz
Dalise Y. Shatz
OIon behalf of PAUSE-SCD Investigators
on behalf of PAUSE-SCD Investigators
Background: Catheter ablation as first-line therapy for ventricular tachycardia (VT) at the time of implantable cardioverter defibrillator (ICD) implantation has not been adopted into clinical guidelines. Also, there is an unmet clinical need to prospectively examine the role of VT ablation in patients with nonischemic cardiomyopathy, an increasingly prevalent population that is referred for advanced therapies globally. Methods: We conducted an international, multicenter, randomized controlled trial enrolling 180 patients with cardiomyopathy and monomorphic VT with an indication for ICD implantation to assess the role of early, first-line ablation therapy. A total of 121 patients were randomly assigned (1:1) to ablation plus an ICD versus conventional medical therapy plus an ICD. Patients who refused ICD (n=47) were followed in a prospective registry after stand-alone ablation treatment. The primary outcome was a composite end point of VT recurrence, cardiovascular hospitalization, or death. Results: Randomly assigned patients had a mean age of 55 years (interquartile range, 46–64) and left ventricular ejection fraction of 40% (interquartile range, 30%–49%); 81% were male. The underlying heart disease was ischemic cardiomyopathy in 35%, nonischemic cardiomyopathy in 30%, and arrhythmogenic cardiomyopathy in 35%. Ablation was performed a median of 2 days before ICD implantation (interquartile range, 5 days before to 14 days after). At 31 months, the primary outcome occurred in 49.3% of the ablation group and 65.5% in the control group (hazard ratio, 0.58 [95% CI, 0.35–0.96]; P =0.04). The observed difference was driven by a reduction in VT recurrence in the ablation arm (hazard ratio, 0.51 [95%CI, 0.29–0.90]; P =0.02). A statistically significant reduction in both ICD shocks (10.0% versus 24.6%; P =0.03) and antitachycardia pacing (16.2% versus 32.8%; P =0.04) was observed in patients who underwent ablation compared with control. No differences in cardiovascular hospitalization (32.0% versus. 33.7%; hazard ratio, 0.82 [95% CI, 0.43–1.56]; P =0.55) or mortality (8.9% versus 8.8%; hazard ratio, 1.40 [95% CI, 0.38–5.22]; P =0.62]) were observed. Ablation-related complications occurred in 8.3% of patients. Conclusions: Among patients with cardiomyopathy of varied causes, early catheter ablation performed at the time of ICD implantation significantly reduced the composite primary outcome of VT recurrence, cardiovascular hospitalization, or death. These findings were driven by a reduction in ICD therapies. Registration: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT02848781.

1 November 2020 in Circulation: Arrhythmia and Electrophysiology
Verified
Journal Article
Closed access
PDF file
CLChih-Min Liu
Chih-Min Liu
SCShih-Lin Chang
Shih-Lin Chang
HCHung-Hsun Chen
Hung-Hsun Chen
WCWei-Shiang Chen
Wei-Shiang Chen
YLYenn-Jiang Lin
Yenn-Jiang Lin
SCShih-Ann Chen
Shih-Ann Chen
Background - Non-pulmonary vein (NPV) trigger has been reported as an important predictor of recurrence post-atrial fibrillation (AF) ablation. Elimination of NPV triggers can reduce the recurrence of post-ablation AF. Deep learning was applied to pre-ablation pulmonary vein computed tomography (PVCT) geometric slices to create a prediction model for NPV triggers in patients with paroxysmal atrial fibrillation (PAF). Methods - We retrospectively analyzed 521 PAF patients who underwent catheter ablation of PAF. Among them, PVCT geometric slices from 358 non-recurrent AF patients (1-3 mm interspace per slice, 20-200 slices for each patient, ranging from the upper border of the left atrium to the bottom of the heart, for a total of 23683 images of slices) were used in the deep learning process, the ResNet34 of the neural network, to create the prediction model of the NPV trigger. There were 298 (83.2%) patients with only pulmonary vein (PV) triggers and 60 (16.8%) patients with NPV triggers +/- PV triggers. The patients were randomly assigned to either training, validation or test groups and their data was allocated according to those sets. The image datasets were split into training (n=17340), validation (n=3491), and testing (n=2852) groups, which had completely independent sets of patients. Results - The accuracy of prediction in each PVCT image for NPV trigger was up to 82.4±2.0%. The sensitivity and specificity were 64.3±5.4% and 88.4±1.9%, respectively. For each patient, the accuracy of prediction for a NPV trigger was 88.6±2.3%. The sensitivity and specificity were 75.0±5.8% and 95.7±1.8%, respectively. The area under the curve (AUC) for each image and patient were 0.82±0.01 and 0.88±0.07, respectively. Conclusions - The deep learning model using pre-ablation PVCT can be applied to predict the trigger origins in PAF patients receiving catheter ablation. The application of this model may identify patients with a high risk of NPV trigger before ablation.

1 July 2020 in Heart Rhythm
Verified
Journal Article
Closed access
FCFa-Po Chung
Fa-Po Chung
CLChin-Yu Lin
Chin-Yu Lin
YSYasuhiro Shirai
Yasuhiro Shirai
PFPiotr Futyma
Piotr Futyma
PSPasquale Santangeli
Pasquale Santangeli
SCShih-Ann Chen
Shih-Ann Chen

30 May 2019 in Journal of Cardiovascular Electrophysiology
Verified
Journal Article
Closed access
PDF file
CLChih‐Min Liu
Chih‐Min Liu
LLLi-Wei Lo
Li-Wei Lo
LYLin Yenn-jiang
Lin Yenn-jiang
CLChin-Yu Lin
Chin-Yu Lin
SCShih-Lin Chang
Shih-Lin Chang
SCShih-Ann Chen
Shih-Ann Chen

9 April 2014 in Journal of Cardiovascular Electrophysiology
Verified
Journal Article
Closed access
PDF file
LYLin Yenn-jiang
Lin Yenn-jiang
SCShih-Lin Chang
Shih-Lin Chang
LLLi-Wei Lo
Li-Wei Lo
SLShien-Fong Lin
Shien-Fong Lin
ECEric Chong
Eric Chong
SCShih-Ann Chen
Shih-Ann Chen

1 February 2023 in Circulation: Arrhythmia and Electrophysiology
Verified
Journal Article
Closed access
MKMing-Jen Kuo
Ming-Jen Kuo
ATAn Nu-Khanh Ton
An Nu-Khanh Ton
LLLi-Wei Lo
Li-Wei Lo
YLYenn-Jiang Lin
Yenn-Jiang Lin
SCShih-Lin Chang
Shih-Lin Chang
SCShih-Ann Chen
Shih-Ann Chen
Background: The presence of abnormal substrate of left atrium is a predictor of atrial fibrillation (AF) recurrence after pulmonary vein isolation. We aimed to investigate the isochronal late activation mapping to access the abnormal conduction velocity for predicting AF ablation outcome. Methods: Forty-five paroxysmal AF patients (30 males, 57.8±8.7 years old) who underwent pulmonary vein isolation were enrolled. Isochronal late activation mapping was retrospectively constructed with 2 different windows of interest: from onset of P wave to onset of QRS wave on surface electrocardiography (W1) and 74 ms tracking back from the end of P wave (W2). Deceleration zone was defined as regions with 3 isochrones (DZa) or ≥4 isochrones (DZb) within a 1 cm radius on the isochronal late activation mapping, and the estimated conduction velocity (ECV) are 0.27 m/s and <0.20 m/s for DZa and DZb, respectively in W2. The distribution of deceleration zone was compared with the location of low-voltage zone (bipolar voltage ≤0.5 mV). Any recurrence of atrial arrhythmias was defined as the primary end point during follow ups after a 3-month blanking period. Results: Pulmonary vein isolation was performed in all patients, and there were 2 patients (4.4%) received additional extrapulmonary vein ablation. After a mean follow-up of 12.7±4.5 months, recurrence of AF occurred in 14 patients (31.1%). Patients with the presence of DZb in W2 had higher AF recurrence (Kaplan-Meier event rate estimates: HR, 9.41 [95% CI, 2.61–33.90]; log-rank P <0.0001). There were 52.6% of the DZb locations in W2 comparable to the distributions of low-voltage zone and 47.4% DZb were distributed in the area without low-voltage zone. Conclusions: Deceleration zone detected by isochronal late activation mapping represents a critical AF substrate, it accurately predicts the AF recurrence following ablation in patients with paroxysmal AF.